Sub30: Protocol for the Sub30 feasibility study of a pre-hospital Extracorporeal membrane oxygenation (ECMO) capable advanced resuscitation team at achieving blood flow within 30 ​min in patients with refractory out-of-hospital cardiac arrest.

Cardiac arrest Extra-corporeal cardiopulmonary resuscitation Extracorporeal membrane oxygenation Pre-hospital medical care

Journal

Resuscitation plus
ISSN: 2666-5204
Titre abrégé: Resusc Plus
Pays: Netherlands
ID NLM: 101774410

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 02 07 2020
revised: 12 09 2020
accepted: 15 09 2020
entrez: 6 1 2021
pubmed: 7 1 2021
medline: 7 1 2021
Statut: ppublish

Résumé

Out-of-hospital cardiac arrest carries a poor prognosis with survival less than 10% in many patient cohorts. Survival is inversely associated with duration of resuscitation as external chest compressions do not provide sufficient blood flow to prevent irreversible organ damage during a prolonged resuscitation. Extracorporeal membrane oxygenation (ECMO) instituted during cardiac arrest can provide normal physiological blood flows and is termed Extracorporeal Cardio-Pulmonary Resuscitation (ECPR). ECPR may improve survival when used with in-hospital cardiac arrests. This possible survival benefit has not been replicated in trials of out-of-hospital cardiac arrests, possibly because of the additional time it takes to transport the patient to hospital and initiate ECPR. Pre-hospital ECPR may shorten the time between cardiac arrest and physiological blood flows, potentially improving survival. It may also mitigate some of the neurological injury that many survivors suffer. Sub30 is a prospective six patient feasibility study. The primary aim is to test whether it is possible to institute ECPR within 30 ​min of collapse in adult patients with refractory out of hospital cardiac arrest (OHCA). The secondary aims are to gather preliminary data on clinical outcomes, resource utilisation, and health economics associated with rapid ECPR delivery in order to plan any subsequent clinical investigation or clinical service. On study days a dedicated fast-response vehicle with ECPR capability will be tasked to out-of-hospital cardiac arrests in an area of London served by Barts Heart Centre. If patients suffer a cardiac arrest refractory to standard advanced resuscitation and meet eligibility criteria, ECPR will be started in the pre-hospital environment. Delivering pre-hospital ECPR within 30 ​min of an out-of-hospital cardiac arrest presents significant ethical, clinical, governance and logistical challenges. Prior to conducting an efficacy study of ECPR the feasibility of timely and safe application must be demonstrated first. Extensive planning, multiple high-fidelity multiagency simulations and a unique collaboration between pre-hospital and in-hospital institutions will allow us to test the feasibility of this intervention in London. The study has been reviewed, refined and endorsed by the International ECMO Network (ECMONet). Clinicaltrials. gov NCT03700125, prospectively registered October 9, 2018.

Sections du résumé

BACKGROUND BACKGROUND
Out-of-hospital cardiac arrest carries a poor prognosis with survival less than 10% in many patient cohorts. Survival is inversely associated with duration of resuscitation as external chest compressions do not provide sufficient blood flow to prevent irreversible organ damage during a prolonged resuscitation. Extracorporeal membrane oxygenation (ECMO) instituted during cardiac arrest can provide normal physiological blood flows and is termed Extracorporeal Cardio-Pulmonary Resuscitation (ECPR). ECPR may improve survival when used with in-hospital cardiac arrests. This possible survival benefit has not been replicated in trials of out-of-hospital cardiac arrests, possibly because of the additional time it takes to transport the patient to hospital and initiate ECPR. Pre-hospital ECPR may shorten the time between cardiac arrest and physiological blood flows, potentially improving survival. It may also mitigate some of the neurological injury that many survivors suffer.
METHODS METHODS
Sub30 is a prospective six patient feasibility study. The primary aim is to test whether it is possible to institute ECPR within 30 ​min of collapse in adult patients with refractory out of hospital cardiac arrest (OHCA). The secondary aims are to gather preliminary data on clinical outcomes, resource utilisation, and health economics associated with rapid ECPR delivery in order to plan any subsequent clinical investigation or clinical service. On study days a dedicated fast-response vehicle with ECPR capability will be tasked to out-of-hospital cardiac arrests in an area of London served by Barts Heart Centre. If patients suffer a cardiac arrest refractory to standard advanced resuscitation and meet eligibility criteria, ECPR will be started in the pre-hospital environment.
DISCUSSION CONCLUSIONS
Delivering pre-hospital ECPR within 30 ​min of an out-of-hospital cardiac arrest presents significant ethical, clinical, governance and logistical challenges. Prior to conducting an efficacy study of ECPR the feasibility of timely and safe application must be demonstrated first. Extensive planning, multiple high-fidelity multiagency simulations and a unique collaboration between pre-hospital and in-hospital institutions will allow us to test the feasibility of this intervention in London. The study has been reviewed, refined and endorsed by the International ECMO Network (ECMONet).
TRIAL REGISTRATION BACKGROUND
Clinicaltrials. gov NCT03700125, prospectively registered October 9, 2018.

Identifiants

pubmed: 33403364
doi: 10.1016/j.resplu.2020.100029
pii: S2666-5204(20)30029-1
pmc: PMC7543759
doi:

Banques de données

ClinicalTrials.gov
['NCT03700125']

Types de publication

Journal Article

Langues

eng

Pagination

100029

Informations de copyright

Crown Copyright © 2020 Published by Elsevier B.V.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Resuscitation. 2017 Mar;112:1-10
pubmed: 28007504
J Am Heart Assoc. 2016 Jan 07;5(1):
pubmed: 26744380
Resuscitation. 2017 Aug;117:109-117
pubmed: 28414164
Resuscitation. 2017 Aug;117:24-31
pubmed: 28552656
J Am Heart Assoc. 2016 Jun 13;5(6):
pubmed: 27412906
Eur Heart J. 2017 Dec 14;38(47):3532-3534
pubmed: 29020366
Crit Care. 2017 Jun 22;21(1):157
pubmed: 28637497
N Engl J Med. 2018 Aug 23;379(8):711-721
pubmed: 30021076
Curr Opin Crit Care. 2014 Jun;20(3):259-65
pubmed: 24785674

Auteurs

Ben Singer (B)

St Bartholomew's Hospital, London, UK.
London's Air Ambulance, UK.

Joshua C Reynolds (JC)

Michigan State University, USA.

Gareth E Davies (GE)

London's Air Ambulance, UK.

Fenella Wrigley (F)

London Ambulance Service, UK.

Mark Whitbread (M)

University of Sussex, UK.

Mark Faulkner (M)

London Ambulance Service, UK.

Ben O'Brien (B)

St Bartholomew's Hospital, London, UK.

Alastair G Proudfoot (AG)

St Bartholomew's Hospital, London, UK.

Anthony Mathur (A)

St Bartholomew's Hospital, London, UK.

Thomas Evens (T)

London's Air Ambulance, UK.

Jane Field (J)

Barts Cardiovascular Clinical Trials Unit, London, UK.

Vivienne Monk (V)

Barts Cardiovascular Clinical Trials Unit, London, UK.

Simon J Finney (SJ)

St Bartholomew's Hospital, London, UK.

Classifications MeSH